
As of the Year 2022, Therapeutic antibodies have become the predominant class of new drugs positively impacting patients across the globe for treating several human diseases including cancer, autoimmune.
Copyright © 2026 BlueTech Media LLP - All Rights Reserved.
Designed by Whyte Wings Media
